The stock of Incyte Corp (NASDAQ: INCY) has decreased by -0.81% when compared to last closing price of $68.73.Despite this, the company has seen a gain of 0.92% in its stock price over the last five trading days. businesswire.com reported 2025-07-02 that WILMINGTON, Del.–(BUSINESS WIRE)–Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Is It Worth Investing in Incyte Corp (NASDAQ: INCY) Right Now?
Incyte Corp (NASDAQ: INCY) has a price-to-earnings ratio that is above its average at 210.92x. The stock has a 36-month beta value of 0.71. Opinions on the stock are mixed, with 9 analysts rating it as a “buy,” 2 as “overweight,” 16 as “hold,” and 0 as “sell.”
The public float for INCY is 190.87M, and at present, short sellers hold a 4.29% of that float. On July 03, 2025, the average trading volume of INCY was 2.03M shares.
INCY’s Market Performance
The stock of Incyte Corp (INCY) has seen a 0.92% increase in the past week, with a 4.38% rise in the past month, and a 11.92% gain in the past quarter. The volatility ratio for the week is 3.17%, and the volatility levels for the past 30 days are at 3.01% for INCY. The simple moving average for the past 20 days is -0.77% for INCY’s stock, with a 0.31% simple moving average for the past 200 days.
Analysts’ Opinion of INCY
Many brokerage firms have already submitted their reports for INCY stocks, with Stifel repeating the rating for INCY by listing it as a “Buy.” The predicted price for INCY in the upcoming period, according to Stifel is $107 based on the research report published on June 16, 2025 of the current year 2025.
INCY Trading at 5.20% from the 50-Day Moving Average
After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.80% of loss for the given period.
Insider Trading
Denton Sheila A., the EVP & General Counsel of Incyte Corp, sale 1,795 shares at $68.00 during a trade that took place back on Jun 03 ’25, which means that Denton Sheila A. is holding 26,504 shares at $122,060 based on the most recent closing price.
Stock Fundamentals for INCY
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.92 for the gross margin
The net margin for Incyte Corp stands at 0.0. The total capital return value is set at 0.04. Equity return is now at value 0.47, with 0.33 for asset returns.
Based on Incyte Corp (INCY), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 8.87. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 69.93.
Currently, EBITDA for the company is 408.16 million with net debt to EBITDA at -4.67. When we switch over and look at the enterprise to sales, we see a ratio of 2.56. The receivables turnover for the company is 5.36for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.04.
Conclusion
To sum up, Incyte Corp (INCY) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
